FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a chemical compound of formula (II), as well as to pharmaceutical compositions containing a chemical compound of formula (II), and to methods of treating various diseases and disorders, associated with NR2B antagonism, e.g. diseases and CNS disorders, such as depression, by administering a chemical compound of formula (II).
EFFECT: in this invention 3,3-difluoropiperidine carbamate heterocyclic compounds are proposed as NR2B NMDA receptor antagonists.
7 cl, 51 ex, 10 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
| COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
| HETEROARYL COMPOUNDS AND USE THEREOF | 2009 |
|
RU2734822C2 |
| METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
| SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-7-YL COMPOUNDS AS THE INHIBITORS OF PDE2 | 2015 |
|
RU2659070C9 |
| THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
| COMPOUND 8-FLUOROPHTHALAZINE-1(2H)-ONE AS INHIBITORS OF BRUTON TYROSINE KINASE | 2012 |
|
RU2622391C2 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| BICYCLIC PIPERAZINE COMPOUNDS | 2012 |
|
RU2628616C2 |
